![]() |
市场调查报告书
商品编码
1348453
输液帮浦的全球市场:规模,占有率,趋势分析(2024年~2030年):MedCoreInfusion Pump Market Size, Share & Trends Analysis | Global | 2024-2030 | MedCore | Includes: Large-Volume Infusion Pumps, Syringe Infusion Pumps, and 3 more |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2023年全球输液帮浦市场规模预估为35亿美元,较上年的34亿美元成长3.1%。预测期内,该市场将继续以 2.6% 的复合年增长率成长,预计最终将达到 42 亿美元。全球输液帮浦市场的现状很大程度上取决于两个主要参与者的存在:Becton Dickinson (BD) 和 B. Braun。
由于多种因素,全球输液帮浦市场正在成长。造成这种增长的一个主要因素是老年人口的增加,这增加了医疗保健领域对输液帮浦的需求。随着老年人越来越依赖复杂的药物治疗,输液帮浦已成为准确、安全地输送药物的重要工具。
老年患者可能面临吞嚥困难和需要密切剂量控制等挑战,但输液帮浦实现的精确和受控给药使他们受益匪浅。随着老年人口的不断扩大,满足老年人独特用药需求的输液帮浦仍然很重要,并有望在医疗保健支援中发挥越来越重要的作用。
2023年,Becton Dickinson (BD) 已成为全球输液帮浦市场无可争议的领导者。BD 对 CareFusion 的策略性收购,结合其广泛的输液治疗产品线,巩固了其在输液帮浦领域的主导地位。具体来说,BD 的Alaris(R) 产品线包括:Alaris(TM) PC 单元、Alaris(TM) 泵浦模组、Alaris(TM) 注射器模组、Alaris(TM) PCA 模组、Alaris(TM) 自动ID 模组、 Alaris( TM) 它是一个模组化系统,包含 (TM) EtCO2 等关键模组,提供针对不同医疗保健环境的全面解决方案。
贝朗2023年稳居全球输液帮浦市场第二位。该公司展现了对创新的坚定承诺,增强了其输液帮浦产品线,特别注重软体改进和节省空间的设计。B. Braun 的 Infusomat(R) 容积泵是全球公认的解决方案,并且已经存在相当长一段时间了,但他们的最新型号 Infusomat(R) Space 值得特别一提。这种紧凑、轻巧的设备设计为可堆迭,优化了空间利用率,并允许将多个泵浦有效地放置在有限的位置。
本报告提供全球输液帮浦市场相关调查,提供市场概要,以及各市场区隔趋势,市场分析与今后的预测等。
In 2023, the worldwide infusion pump market boasted a total worth of $3.5 billion, marking a 3.1% uptick from the previous year when it stood at $3.4 billion. Projections indicate a continued growth trajectory throughout the forecast period, with a compound annual growth rate (CAGR) of 2.6%, ultimately reaching an estimated value of $4.2 billion. Notably, the current landscape of the global infusion pump market is predominantly influenced by the presence of two key players, namely Becton Dickinson (BD) and B. Braun.
Our extensive medical market research efforts encompassed a comprehensive evaluation of more than 25 infusion pump companies spanning across all seven continents. Employing a rigorous methodology, we delved into various facets of the market, including market sizes, unit sales, company market shares, and generated precise forecasts. The complete report suite dedicated to the global infusion pump market encompasses a range of categories, including large-volume infusion pumps, syringe infusion pumps, patient-controlled analgesia (PCA) infusion pumps, electronic ambulatory infusion pumps, and disposable ambulatory infusion pumps.
The global infusion pump market is on an upward trajectory, driven by several factors. A significant contributor to this growth is the increasing elderly population, which has heightened the demand for infusion pumps in the realm of healthcare. As older individuals increasingly rely on complex medication regimens, infusion pumps have emerged as indispensable tools for ensuring the precise and safe delivery of pharmaceuticals.
Senior patients, who may face challenges such as difficulty swallowing or the need for meticulous dosage management, derive substantial benefits from the precise and controlled administration of medications facilitated by infusion pumps. As the demographic of elderly individuals continues to expand, the significance of infusion pumps in meeting their specific medication requirements remains paramount and is expected to play an increasingly critical role in healthcare assistance.
In the year 2023, Becton Dickinson (BD) emerged as the undisputed leader in the global infusion pump market. BD's strategic acquisition of CareFusion, coupled with its extensive IV therapy product line, firmly established its dominance in the IV infusion pump sector. Notably, BD's Alaris® product line distinguishes itself as a modular system encompassing vital modules such as the Alaris™ PC Unit, Alaris™ Pump Module, Alaris™ Syringe Module, Alaris™ PCA Module, Alaris™ Auto-ID Module, and Alaris™ EtCO2, providing comprehensive solutions tailored for diverse healthcare settings.
Close on its heels, B. Braun secured the second position in the global infusion pump market for the year 2023. The company showcased a strong commitment to innovation, enhancing its infusion pump product lines with a particular emphasis on software improvements and space-efficient designs. B. Braun's Infusomat® volumetric pump, a globally recognized solution, has been available for a significant duration, and its latest iteration, the Infusomat® Space, deserves special mention. This compact and lightweight device is designed for stackability, optimizing space utilization and enabling the efficient placement of multiple pumps in limited areas.
The remainder of the market share was distributed among various competitors, each focusing on specific segments, with only a handful competing across the entire spectrum. Companies like BD and B. Braun enjoy a distinctive advantage in this market due to their ability to offer a diverse range of infusion pumps, serving as comprehensive one-stop solutions for healthcare facilities seeking to expand their pump capabilities.